Evropska unija - slovenščina - EMA (European Medicines Agency)

biogen netherlands b.v. - natalizumab - multiple skleroza - selektivni imunosupresivi - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 in 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Evropska unija - slovenščina - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

emporio medical d.o.o. - jod - raztopina za injiciranje - jod 1 mg / 1 ml - joksaglinska kislina

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - vigabatrin - filmsko obložena tableta - vigabatrin 500 mg / 1 tableta - vigabatrin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

emporio medical d.o.o. - jod - raztopina za injiciranje - jod 1 nedefinirano / 1 nedefinirano - joksaglinska kislina

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

infuzija

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

injekcije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

injekcije

Evropska unija - slovenščina - EMA (European Medicines Agency)

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibacterials za sistemsko uporabo, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Evropska unija - slovenščina - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - verteporfin - myopia, degenerative; macular degeneration - oftalmologi - visudyne je primerna za zdravljenje:odrasli z exudative (mokro) starostna degeneracija rumene pege (amd) s pretežno klasičnih subfoveal choroidal neovascularisation (cnv) ali;za odrasle z subfoveal choroidal neovascularisation sekundarne patološke kratkovidnost.